Supplements and Featured Publications

The Transformative Approach of TEVIMBRA® (tislelizumab-jsgr) in Managing ESCC and GC/GEJC

2025 Year in Review: Multiple Myeloma

2025 Year in Review: Idiopathic Pulmonary Fibrosis

Expert Consensus on Essential Characteristics of Oncology Value-Based Payment

The Evolving Role of Subcutaneous Therapies in EGFR+ NSCLC

The Burden of the Rare Kidney Disorder Focal Segmental Glomerulosclerosis (FSGS)

2025 Year in Review: Lymphoma

The Economics of Atopic Dermatitis: From Real-World Burden to Value- Driven Treatment Strategies

2025 Year in Review: Clostridioides difficile Infection

Equitable Management of Atopic Dermatitis: Treatment Considerations Across Patient Populations

2025 Year in Review: Neurofibromatosis Type 1 With Plexiform Neurofibromas

Modernizing COPD Management: Guideline Evolution, Therapeutic Advances, and Practical Insights

Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations

Clinical and Economic Value of ENTYVIO® (vedolizumab): Implications for Ulcerative Colitis and Crohn Disease Management

Managing HIV in 2025: Optimizing Treatment After Virologic Suppression

Exploring Emerging Therapies in Myasthenia Gravis

Clinical and Economic Considerations for Nivolumab-Based Therapy for Resectable Non–Small Cell Lung Cancer

Continuous Glucose Monitoring as a Driver of Quality and Value: Evidence and Perspectives from Clinical and Managed Care Leaders

The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment

Exploring Novel Treatment Options for Neurofibromatosis Type 1 With Plexiform Neurofibromas

CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges

Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data

The Growing Role of Prescription Digital Therapeutics in the Treatment of Psychiatric Disorders

Long-Acting Injectable Administration In Schizophrenia With Insights From Genoa Healthcare® Pharmacy

Alzheimer’s Disease: Advancing Early Diagnosis and Multidisciplinary Care

Guideline-Based Strategies for the Management of Cardiovascular-Renal-Metabolic Conditions: Focus on Chronic Kidney Disease

Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease

Managing Obesity: Strategic Considerations for Payers

Advancing Individualized Care Approaches for Dry Eye Disease

Navigating Cutaneous Squamous Cell Carcinoma: Epidemiological Trends, Treatment Strategies, and Collaborative Care Approaches
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Pirtobrutinib Outperforms Bendamustine-Rituximab in Frontline CLL/SLL
4
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
5




